Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 196

1.

Predictors of metabolic monitoring among schizophrenia patients with a new episode of second-generation antipsychotic use in the Veterans Health Administration.

Shi L, Ascher-Svanum H, Chiang YJ, Zhao Y, Fonseca V, Winstead D.

BMC Psychiatry. 2009 Dec 18;9:80. doi: 10.1186/1471-244X-9-80.

PMID:
20021664
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Metabolic monitoring in veterans with schizophrenia-related disorders and treated with second-generation antipsychotics: findings from a Veterans Affairs-based population.

Hsu C, Ried LD, Bengtson MA, Garman PM, McConkey JR, Rahnavard F.

J Am Pharm Assoc (2003). 2008 May-Jun;48(3):393-400. doi: 10.1331/JAPhA.2008.07007.

PMID:
18595825
[PubMed - indexed for MEDLINE]
3.

[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].

Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL, Azorin JM; avec le soutien institutionnel du laboratoire Lilly.

Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9. French.

PMID:
19748369
[PubMed - indexed for MEDLINE]
4.

Lipid monitoring in patients with schizophrenia prescribed second-generation antipsychotics.

Weissman EM, Zhu CW, Schooler NR, Goetz RR, Essock SM.

J Clin Psychiatry. 2006 Sep;67(9):1323-6.

PMID:
17017817
[PubMed - indexed for MEDLINE]
5.

[Metabolic testing rates after initiation of antipsychotic treatment in persons initially treated by conventional mood-stabilizers].

Verdoux H, Gaudron Y, Auleley GR, Deligne J, Blum-Boisgard C, Thiébaut A, Tournier M.

Encephale. 2013 May;39 Suppl 1:S22-8. doi: 10.1016/j.encep.2012.10.009. Epub 2012 Dec 13. French.

PMID:
23246328
[PubMed - indexed for MEDLINE]
6.

Quality of monitoring for metabolic effects associated with second generation antipsychotics in patients with schizophrenia on public insurance.

Moeller KE, Rigler SK, Mayorga A, Nazir N, Shireman TI.

Schizophr Res. 2011 Mar;126(1-3):117-23. doi: 10.1016/j.schres.2010.11.015. Epub 2010 Dec 18.

PMID:
21168994
[PubMed - indexed for MEDLINE]
7.

Monitoring metabolic side effects when initiating treatment with second-generation antipsychotic medication.

Weissman E, Jackson C, Schooler N, Goetz R, Essock S.

Clin Schizophr Relat Psychoses. 2012 Jan;5(4):201-7. doi: 10.3371/CSRP.5.4.4.

PMID:
22182457
[PubMed - indexed for MEDLINE]
8.

Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims data.

Morrato EH, Newcomer JW, Allen RR, Valuck RJ.

J Clin Psychiatry. 2008 Feb;69(2):316-22.

PMID:
18251625
[PubMed - indexed for MEDLINE]
9.

Metabolic risk status and second-generation antipsychotic drug selection: a retrospective study of commercially insured patients.

Morrato EH, Cuffel B, Newcomer JW, Lombardo I, Kamat S, Barron J.

J Clin Psychopharmacol. 2009 Feb;29(1):26-32. doi: 10.1097/JCP.0b013e31819294cb.

PMID:
19142103
[PubMed - indexed for MEDLINE]
10.

The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs.

Falissard B, Mauri M, Shaw K, Wetterling T, Doble A, Giudicelli A, De Hert M.

Int Clin Psychopharmacol. 2011 Nov;26(6):291-302. doi: 10.1097/YIC.0b013e32834a5bf6.

PMID:
21876442
[PubMed - indexed for MEDLINE]
11.

Metabolic syndrome in schizophrenia: a comparative study of antipsychotic-free/naïve and antipsychotic-treated patients from India.

Pallava A, Chadda RK, Sood M, Lakshmy R.

Nord J Psychiatry. 2012 Jun;66(3):215-21. doi: 10.3109/08039488.2011.621977. Epub 2011 Oct 24.

PMID:
22017264
[PubMed - indexed for MEDLINE]
12.

[Metabolic side effects of risperidone in early onset schizophrenia].

Goeb JL, Marco S, Duhamel A, Kechid G, Bordet R, Thomas P, Delion P, Jardri R.

Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. Epub 2009 Dec 1. French.

PMID:
20620267
[PubMed - indexed for MEDLINE]
13.

Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services.

Van Dorn RA, Andel R, Boaz TL, Desmarais SL, Chandler K, Becker MA, Howe A.

J Clin Psychiatry. 2011 Apr;72(4):502-8. doi: 10.4088/JCP.10m06618.

PMID:
21527125
[PubMed - indexed for MEDLINE]
14.

Assessment of monitoring for glucose and lipid dysregulation in adult Medi-Cal patients newly started on antipsychotics.

Barnett M, VonMuenster S, Wehring H, Popish S, McDonald K, Walker VM, Perry P.

Ann Clin Psychiatry. 2010 Feb;22(1):9-18.

PMID:
20196978
[PubMed - indexed for MEDLINE]
15.

Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs.

Morrato EH, Druss B, Hartung DM, Valuck RJ, Allen R, Campagna E, Newcomer JW.

Arch Gen Psychiatry. 2010 Jan;67(1):17-24. doi: 10.1001/archgenpsychiatry.2009.179.

PMID:
20048219
[PubMed - indexed for MEDLINE]
16.

Evaluation of health services use following the initiation of risperidone long-acting therapy among schizophrenia patients in the veterans health administration.

Ren XS, Crivera C, Sikirica M, Dirani R, Qian S, Kazis LE.

J Clin Pharm Ther. 2011 Jun;36(3):383-9. doi: 10.1111/j.1365-2710.2010.01211.x. Epub 2010 Nov 10.

PMID:
21062329
[PubMed - indexed for MEDLINE]
17.

Monitoring veterans for metabolic side effects when prescribing antipsychotics.

Mittal D, Li C, Williams JS, Viverito K, Landes RD, Owen RR.

Psychiatr Serv. 2013 Jan;64(1):28-35.

PMID:
23117285
[PubMed - indexed for MEDLINE]
18.

Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review.

Valenstein M, Ganoczy D, McCarthy JF, Myra Kim H, Lee TA, Blow FC.

J Clin Psychiatry. 2006 Oct;67(10):1542-50.

PMID:
17107245
[PubMed - indexed for MEDLINE]
19.

Diabetes prevalence and hospital and pharmacy use in the Veterans Health Administration (1994). Use of an ambulatory care pharmacy-derived database.

Pogach LM, Hawley G, Weinstock R, Sawin C, Schiebe H, Cutler F, Zieve F, Bates M, Repke D.

Diabetes Care. 1998 Mar;21(3):368-73.

PMID:
9540017
[PubMed - indexed for MEDLINE]
20.

The prevalence of metabolic syndrome in Korean patients with schizophrenia receiving a monotherapy with aripiprazole, olanzapine or risperidone.

Lee NY, Kim SH, Jung DC, Kim EY, Yu HY, Sung KH, Kang UG, Ahn YM, Kim YS.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jul 1;35(5):1273-8. doi: 10.1016/j.pnpbp.2011.03.022. Epub 2011 Apr 14.

PMID:
21513765
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk